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Background: Endoscopic resection of sinonasal Inverted Papilloma (SNIP) tumors has been shown to reduce intra-
operative blood loss and recovery time compared to open approaches. The purpose of this study is to investigate
the incidence and requirements of blood transfusion for endoscopic SNIP surgeries.
Methods: An individual retrospective cohort study of endoscopic SNIP surgeries over a 10-year period was
performed. Age, sex, pre-existing co-morbidity, use of anti-coagulants, tumor type and stage, time of surgery,
estimated blood loss and the requirement for blood transfusion were recorded.
Results: 82 patients were included (57 males, 25 females). 4 (5%) Stage 1, 7 (8.5%) Stage 2, 62 (75.5%) Stage 3 and
9 (11%) Stage 4 SNIP tumors were identified according to the Krouse staging system. 3 (4%) patients required
blood transfusion. 3 of the 9 (33%) Stage 4 tumors required blood transfusion. Stage 4 tumors were significantly
associated with blood transfusion (p < 0.05). Higher staged tumors were associated with greater blood loss
(p < 0.05) than lower staged cases. No other tumor stage required blood transfusion and no other pre-operative
variable was associated with requirement for blood transfusion.
Conclusion: Endoscopic SNIP resections rarely require blood transfusions. No pre-operative factor other than tumor
stage is associated with the requirement for blood transfusion. We would therefore suggest that only Stage 4 SNIP
tumors require pre-operative type and screen.
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Sinonasal Inverted Papilloma (SNIP) is a benign epithe-
lial growth occurring in the nose and paranasal sinuses
[1]. These tumors commonly originate in the lateral
nasal wall and/or middle meatus and can later extend to
the surrounding paranasal sinuses [1]. Complete excision
is the treatment of choice for these locally aggressive
tumors with malignant potential [1-4]. Advances in
endoscopic technology and instrumentation have im-
proved visualization and surgical outcomes [1]. The evi-
dence now suggests that endoscopic SNIP resection
gives as good, if not better results than open approaches
[5-8]. Endoscopic tumor resections are less invasive and
associated with reduced surgical time, anaesthesia risk,
shorter hospital stay, fewer intra-operative complications
and lower recurrence rates when compared to the* Correspondence: arhabib9@gmail.com
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reproduction in any medium, provided the orprevious open craniofacial approach [3,4]. Nevertheless,
excision of these tumors may cause significant bleeding
and may occasionally require blood transfusion [4,9].
Blood transfusions restore and maintain circulating
blood volume, correct anaemia and coagulation disor-
ders [10]. However, allogeneic blood transfusions may
pose a risk for transmissible diseases and adverse reac-
tions [11]. In order to ensure accurate and compatible
use of donor units, blood ordering practices such as type
and screen testing and crossmatching have been utilized
by transfusion laboratories [12]. The recipient’s blood is
type and screened to determine ABO and Rh group and
presence of RBC alloantibodies [12,13]. Crossmatching
is utilized to determine patient and donor RBC, plasma
and antibody compatibility [13]. This can be done elec-
tronically in some hospitals to save time and resources,
as opposed to serological testing [14]. Although blood-
ordering protocols for elective surgery are present to in-
crease patient safety, practices of over-ordering units cantd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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perienced staff or inadequate transfusion prediction
models [11,12,15]. To assess the efficiency of routine
blood ordering practices in elective surgery, several
studies have observed the ratio of crossmatched to
transfused patients, average number of units trans-
fused for particular procedures and the transfusion
probability coefficient (number of transfused patients/
number of procedures) [9,12,15,16]. These studies
have found that a tendency towards over-ordering of
blood can consume blood bank resources and in-
crease blood outdating [9,14-17].
It is unclear whether routine requisitions of blood are
necessary for patients who undergo endoscopic SNIP
surgery. To investigate the incidence and requirements
for blood transfusion, we have conducted a retrospective
chart review of endoscopic SNIP resections at our
institution.
Methods
A retrospective chart review of endoscopic SNIP resec-
tions performed at the St. Paul’s Sinus Centre (SPSC)
between April 2000 to August 2010. This is a tertiary
level sinus centre located at the University of British
Columbia in Vancouver, Canada. The charts of those pa-
tients who had undergone computer assisted endoscopic
resections were examined for patient demographic data,
intra-operative details, type and screen ± crossmatch
requisitions and the requirement for blood transfusion.
Histopathological examination by the St. Paul’s Hospital
Laboratory was used to determine tumor type from
intra-operative specimens.
Patient demographic variables included age and sex.
Pre-operative measurements consisted of the presence
of pre-existing co-morbidities, previous sinus surgery,
use of anti-coagulants, tumor stage, pre-operative
hemoglobin and type and screen testing ± crossmatch-
ing. Patients taking anti-coagulation medication discon-
tinued them 1 week prior to surgery. In addition, time
of surgery, total blood loss and blood transfusion
requirement were also documented. Blood loss esti-
mates and time of surgery were ascertained from
post-operative surgical notes and anaesthesia records.Table 1 Krouse staging system for inverted papilloma
T1 Tumor totally confined to the nasal cavity, without extension into the
cavity, or can be bulky and extensive within the nasal cavity, but must
must be no conc
T2 Tumor involving the ostiomeatal complex, and ethmoid sinuses, and/or
the nasal cavity. There must b
T3 Tumor involving the lateral, inferior, superior, anterior, or posterior walls
or without involvement of the medial portion of the maxillary sinus,
malig
T4 All tumors with an extranasal/extrasinus extension to involve adjacent, c
the pterygomaxillary space. All tuA fellowship trained Rhinologist (VSS) evaluated
tumor stage pre-operatively from Computed Tomog-
raphy (CT) scans and rigid nasal endoscopy. The
Krouse staging system was used to evaluate all SNIP
(Table 1) [18]. The senior author was present
throughout all surgeries. The tumor was debulked
piecemeal and the site of origin identified. The tumor
was removed in its entirety and the bone underlying
the origin was drilled to reduce any chance of recur-
rence. Biopsies were taken from all margins to ensure
clearance. Hemostasis was achieved using suction dia-
thermy for specific bleeding vessels and, on occasion,
if significant general oozing was experienced topical
epinephrine soaked neuropatties were used.
The incidence of type and screen testing ± cross-
matching was determined from the St Paul’s Transfu-
sion Laboratory, through electronic and printed
records. Patients who had undergone type and screen
testing had their blood group identified and screened
for the presence of Rh antibodies. The decision
whether to type and screen a patient was made by
the senior author along with the pre-assessment staff
and anesthesiologist. If the surgical procedure had the
potential to require blood transfusion, as judged by
the senior author, crossmatching was completed with
the required units reserved. All blood crossmatching
was electronically completed through the Transfusion
Laboratory. Similarly, blood transfusions were evalu-
ated through Laboratory records and included total
administered units. The amount of blood transfused
was determined by evaluating the total amount of
blood lost, the rate of blood loss, anesthesiology con-
cern and the patient’s overall health.
The study outcomes were occurrence of “type &
screen”, “cross-match” and “blood transfusion”. They
were defined as binary variables in the analysis. For each
outcome both univariate and multivariate logistic regres-
sion models were fitted to patient demographics and
intra-operative variables with the occurrence of the out-
come of interest as the dependent variable. A two-sided
P value of less than 0.05 was considered to indicate stat-
istical significance. Statistical analysis was conducted
using Prism GraphPad Version 5.0.sinuses. The tumor can be localized to one wall or region of the nasal
not extend into the sinuses or into any extranasal compartment. There
urrent malignancy.
the medial portion of the maxillary sinus, with or without involvement of
e no concurrent malignancy.
of the maxillary sinus, the sphenoid sinus, and/or the frontal sinus, with
the ethmoid sinuses, or the nasal cavity. There must be no concurrent
nancy.
ontiguous structures such as the orbit, the intracranial compartment, or
mors associated with malignancy.
Figure 1 Mean total blood loss (ml) versus Krouse Staging for
Inverted Papilloma.
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Total population
82 patients were identified as having undergone com-
puter assisted endoscopic resections of SNIP in the
study period, consisting of 57 (70%) males and 25 (30%)
females. The mean age was 55 years. 23 (28%) patients
had pre-existing co-morbidities, such as diabetes, hyper-
tension, cardiovascular disease, liver disease and/or
kidney disease. 6 (7%) patients were concurrently on a
course of anti-coagulants, such as warfarin, acetylsali-
cylic acid or clopidogrel bisulfate. 45 (55%) of the total
cases were primary endoscopic sinonasal IP resections.
No patients were found to have pre-operative hemog-
lobin below 10 g/dL. No significant association was
found between requiring blood transfusion and the use
of anticoagulants, pre-existing co-morbidity, revision
surgery or pre-operative hemoglobin (p > 0.05). The
study population included 4 (5%) Krouse Stage 1, 7
(8.5%) Stage 2, 62 (75.5%) Stage 3 and 9 (11%) Stage 4
IP tumors (Table 2).
Transfusion
3 (4%) patients required blood transfusion, all of whom
had Krouse Stage 4 tumors. 3 of 9 (33%) Stage 4 tumors
therefore required blood transfusion. Mean total blood
loss for Stage 4 tumors (911 ml) was greater than Stage
3 (461 ml), Stage 2 (636 ml) and Stage 1 tumors (71 ml)
(Figure 1). The three transfusion cases received one, two
or four units of blood respectively. Higher staged tumors
were associated with greater total blood loss than lower
staged cases (p < 0.05). Stage 4 tumors were significantly
associated with blood transfusion (p < 0.05). No signifi-
cant association was found between tumor stage and
time of surgery (p > 0.05). Overall, 1 in 27 SNIP cases
were found to require blood transfusion. Higher staged
tumors (Stage 3 and 4) that were found to have signifi-
cant bleeding during surgery, the transfusion ratioTable 2 Demographic and pre-operative details of total
study population




Pre-existing co-morbidity 23 (28%)
Use of anti-coagulants 6 (7%)





T1 4 (5%)increased to 1 in 24. For Krouse Stage 4, the transfusion
ratio was 1 in 3.
Type and screen testing
21 (26%) patients underwent type and screen testing. No
association was found in patients’ type and screen
tested and the presence of pre-existing co-morbidities
(p = 0.32), use of anti-coagulants (p = 0.73), and pre-
operative hemoglobin (p = 0.74). Of these, 5 (24%) were
Stage 4, 14 (67%) Stage 3, and 2 (9%) were Stage 2
tumors. No Stage 1 tumors were type and screen tested
(Table 3). Of all type and screened patients, only 3 (14%)
required blood transfusion, all of which were Stage 4
tumors. 2 of 5 (40%) Krouse Stage 4 SNIPs that were
screened did not require blood transfusion. Amongst
the three cases requiring blood transfusion, 2 (66%) were
not pre-screened. 18 (86%) of the type and screened
cases did not require blood transfusion. The type and
screen to transfusion ratio was 7:1 (Table 3).
Crossmatching
5 (6%) patients underwent blood crossmatch testing. Of
these, 3 (60%) were Stage 4 and 2 (40%) were Stage 3 IPTable 3 Krouse staging for cases type and screen tested
and type and screen to transfusion ratio






Type and screen to transfusion ratio 7:1
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require blood crossmatch testing (Table 4). Of all blood
crossmatched patients, 3 (60%) required blood transfu-
sion. These cases only consisted of Stage 4 IP tumors.
No other crossmatched tumor stage other than Stage 4
required blood transfusion. Stage 4 tumors requiring
blood crossmatch testing had greater total blood loss
(2300 ml) than those without crossmatch testing
(217 ml). The crossmatch to transfusion ratio was 5:3
(Table 4). No significant association was found between
the crossmatched patients and the presence of pre-
existing co-morbidities (p = 0.78), use of anti-coagulants
(p = 0.82), and pre-operative hemoglobin (p = 0.41).
Expenditure
The estimated fees for each procedure were obtained
from the Transfusion Laboratory and the Department of
Finance to assess the cost of our current blood ordering
protocol. The direct cost of type and screen testing was
estimated to be $67.49. This included identification of
patient blood type (ABO), presence of Rh groups and
screening of circulating antibodies. Therefore, the total
expenditure for all patients’ type and screen tested
(n = 21) was approximately $1417.29. Similarly, the dir-
ect cost for electronic crossmatch testing was estimated
to be $8.18. Patients’ blood was digitally matched to the
donor blood bank to determine compatibility. Therefore,
the total expenditure for all patients crossmatch tested
(n = 5) was approximately $40.90. The combined cost of
blood ordering procedures was $1458.19. All prices have
been provided in Canadian dollars.
Discussion
In this study we have observed that SNIP stage, operat-
ing time and total blood loss are the only measures that
are associated with blood transfusion. It therefore ap-
pears that the only pre-operative variable identified in
this study that can be used to predict who may require
blood transfusion is tumor stage. This highlights the im-
portance of a detailed pre-operative patient assessment
to accurately stage the tumor. Advances in CT imagingTable 4 Krouse staging for crossmatched cases and
crossmatch to transfusion ratio






Crossmatch to transfusion ratio 5:3and endoscopic visualization have allowed for better de-
termination of the extent of SNIP tumors, allowing for
improved assessment and surgical removal [19]. The
amount of blood a patient would receive if transfused
could not be predicted before surgery. Vascularity of the
tumor or tumor bed, site of origin of the tumor and ex-
tent of resection during tumor removal were factors en-
countered intra-operatively that could not be accurately
predicted pre-operatively. The study was performed in a
tertiary referral sinus centre where the SNIP cases seen
tend to be advanced, with 86% being Krouse Stage 3 or
above. The incidence of blood transfusion may be even
lower in non-tertiary centres where the cases are more
likely to be of a lower Krouse stage.
Information gained from conducting an internal audit
of surgical blood orders made at the St. Paul’s Sinus
Centre can be used to establish precise guidelines for
the allocation of blood resources. As described by Lin
et al. (2006), for elective procedures where transfusion
probability is less than five percent, pre-operative blood
ordering can be disregarded [12]. We have found that
the incidence of blood transfusion using the endoscopic
approach for all sinonasal tumor resections is 4%.
Approximately one out of seven patients type and screen
tested was subsequently transfused (Figure 1). Those
patients that were type and screened but not transfused
had lower SNIP staging than those who required
transfusion.
Our study suggests high SNIP tumor stage is an import-
ant factor that needs to be considered when deciding
which patients require type and screen preoperatively. By
determining SNIP stage from pre-operative CT imaging
and endoscopic assessment, an efficient allocation of
blood resources and surgical strategies can be made. Type
and screen testing was approximately eight times more
costly than electronic crossmatching, and therefore if un-
necessary testing can be reduced a significant saving can
be made. The overall incidence of blood transfusion was
less than 5%. We therefore propose that routine type and
screen is not required for all endoscopic resections of
SNIP. However, blood transfusion was required in 33% of
Stage 4 tumors, well above the 5% cut off suggested. We
therefore recommend that type and screen testing should
only be requested for Stage 4 SNIPs. If this protocol was
followed in our series then all 9 Stage 4 SNIPs would have
required type and screen testing at a cost of C$607.41, an
overall saving of C$809.88. Introducing blood-ordering
guidelines for surgical procedures can result in reduced
costs, a lowering of the consumption of valuable blood
bank resources as well as a decrease in blood outdating.
Conclusion
Endoscopic SNIP resections rarely require blood transfu-
sions. No pre-operative factor other than tumor stage
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sion. We therefore recommend that only those patients
with Stage 4 SNIP tumors require pre-operative type
and screen.
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